Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine-Reference-Cited by-同舟云学术

Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine

Published:2022-08-13 Issue:10 Volume:36 Page:2548-2550
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Breccia M.^ORCID,Piciocchi A.,Messina M.^ORCID,Soddu S.,De Stefano V.,Bellini M.,Iurlo A.,Martino B.,Siragusa S.,Albano F.,Mora B.,Fazi P.,Vignetti M.,Guglielmelli P.^ORCID,Palandri F.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01675-1.pdf

Reference13 articles.

1. Palandri F, Breccia M, De Stefano V, Passamonti F. Philadelphia-negative chronic myeloproliferative neoplasms during the COVID-19 pandemic: challenges and future scenarios. Cancers. 2021;13:4750.

2. Simpson-Poirier K, Harnois M, Olney HJ, Sirhan S, Gratton MO, Assouline S, et al. Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group. Am J Hematol. 2021;96:E200–e203.

3. Breccia M, Piciocchi A, De Stefano V, Finazzi G, Iurlo A, Fazi P, et al. COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey. Leukemia. 2020;34:2813–4.

4. Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7:e737–e745.

5. Palandri F, Piciocchi A, De Stefano V, Breccia M, Finazzi G, Iurlo A, et al. How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey. Leukemia. 2020;34:2805–8.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of BNT162b2 vaccine prior to COVID‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study;Cancer Medicine;2023-10-25

2. IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY.;Mediterranean Journal of Hematology and Infectious Diseases;2023-04-28

3. Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine;Frontiers in Oncology;2023-02-14

4. SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms;Research and Practice in Thrombosis and Haemostasis;2023-02